(a) The tumor shows focal glandular architecture along with solid areas (100×, H&E). (b, c) The solid component exhibits prominent lymphocytic infiltrate with tumor heterogeneity (100×, H&E). (d) The ...
The first drug for a rare and difficult-to-treat type of ovarian cancer has been granted accelerated approval by the Food and Drug Administration (FDA). The treatment, called avutometinib plus ...
Physician to the General Infirmary at Gloucester. One Volums, Octavo, 308 pages, and Five Plates. London, 1819.
Ovarian cancer incidence shows significant global variation, with highest rates in Eastern Europe and lowest in Africa and Asia. Despite declining incidence rates, ovarian cancer prognosis remains ...
Micropulse laser photocoagulation is a safe and effective treatment option for early-stage central serous chorioretinopathy that improves anatomical and visual function. Micropulse laser ...
Allan Albig receives funding from the National Institute of Health. Think back to that basic biology class you took in high school. You probably learned about organelles, those little “organs” inside ...
Central serous retinopathy (or CSR, also known as central serous chorioretinopathy, or CSCR), is a disease of the eye, most notably the retina. This condition results from fluid building up underneath ...
Membrane proteins expressed on ovarian cancer-derived extracellular vesicles (EVs) are shown to be suitable biomarkers for ovarian cancer detection. Researchers at Nagoya University (Japan) identified ...
A study led by Nagoya University in Japan has identified three previously unknown membrane proteins in ovarian cancer. Using a unique technology consisting of nanowires with a polyketone coating, the ...
Please provide your email address to receive an email when new articles are posted on . Central serous chorioretinopathy is a common chorioretinal disease characterized by a buildup of subretinal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback